Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease
Conclusions: Efficacy and safety profiles of prolonged adalimumab treatment in children with Crohn's disease were consistent with IMAgINE 1 and adult Crohn's disease adalimumab trials.
Source: Inflammatory Bowel Diseases - Category: Gastroenterology Tags: Original Clinical Articles Source Type: research
More News: Children | Corticosteroid Therapy | Crohn's Disease | Humira | Inflammatory Bowel Disease | Pediatrics | Study